High-dose Furmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Meningeal Metastasis
Sun Yat-sen University
Sun Yat-sen University
Bristol-Myers Squibb
Taipei Veterans General Hospital, Taiwan
Shanghai Chest Hospital
Guangzhou Medical University
Tianjin Medical University Cancer Institute and Hospital
University of Pittsburgh
St. Jude Children's Research Hospital
University of Kentucky
Guangzhou Medical University
Guangzhou Medical University
Guangzhou Medical University
Sun Yat-sen University
Guangzhou Medical University
Guangzhou Medical University
Guangzhou Medical University
The First Hospital of Jilin University
Fundación GECP
Henan Cancer Hospital
Zhejiang Cancer Hospital
Blueprint Medicines Corporation
Sichuan University
Xiangya Hospital of Central South University
Sun Yat-sen University
Three Gorges Hospital of Chongqing University
Sun Yat-sen University
The First Hospital of Jilin University
Shanghai Pudong Hospital
Sun Yat-sen University
Northwestern University
Saint John's Cancer Institute
Northwestern University
The First Hospital of Jilin University
The First Hospital of Jilin University
UNC Lineberger Comprehensive Cancer Center
University of Arizona
Guangzhou Medical University
Shandong Cancer Hospital and Institute
Shandong Cancer Hospital and Institute
Eli Lilly and Company
University Hospital, Brest